
|Videos|February 2, 2016
Dr. Kenneth Wang on Forgoing Screening for Barrett's Esophagus
Author(s)Kenneth Wang, MD
Kenneth Wang, MD, director of the Advanced Endoscopy Group and Esophageal Neoplasia Clinic, Mayo Clinic, discusses his opposition for Barrett's esophagus screening as a preventative measure for esophageal adenocarcinoma.
Advertisement
'Kenneth Wang, MD, director of the Advanced Endoscopy Group and Esophageal Neoplasia Clinic, Mayo Clinic, discusses his opposition for screening for Barrett's esophagus as a preventative measure for esophageal adenocarcinoma. Wang says currently, a gastroenterologist will most commonly screen a patient for Barrett's esophagus with an endoscopy. Wang says the practice of endoscopies do not result in many revelations of Barrett's esophagus, partially due to not enough biopsies being taken.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves Iberdomide, the First CELMoD for Relapsed/Refractory Multiple Myeloma
2
ASTRO Issues Updated Clinical Practice Guideline on RT for Pancreatic Cancer
3
With 4 Guideline-Preferred Options, CNS Activity Is Deciding Frontline ROS1+ NSCLC Therapy
4
FAQ: When and How to Discontinue Lenalidomide Maintenance in Multiple Myeloma
5




































